| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JMB.2005.04.050 |
| P698 | PubMed publication ID | 15913651 |
| P50 | author | Joost Schymkowitz | Q6276111 |
| Benoît Stijlemans | Q37320172 | ||
| Serge Muyldermans | Q39183359 | ||
| Lode Wyns | Q48739361 | ||
| Cécile Vincke | Q81780821 | ||
| P2093 | author name string | Katja Conrath | |
| Klaas Decanniere | |||
| Remy Loris | |||
| P2860 | cites work | Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination | Q26778405 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 112-125 | |
| P577 | publication date | 2005-07-01 | |
| P1433 | published in | Journal of Molecular Biology | Q925779 |
| P1476 | title | Antigen binding and solubility effects upon the veneering of a camel VHH in framework-2 to mimic a VH | |
| P478 | volume | 350 |
| Q28485195 | Affinity is an important determinant of the anti-trypanosome activity of nanobodies |
| Q34995448 | Analysis and modeling of the variable region of camelid single-domain antibodies |
| Q27677883 | Atypical Antigen Recognition Mode of a Shark Immunoglobulin New Antigen Receptor (IgNAR) Variable Domain Characterized by Humanization and Structural Analysis |
| Q36121467 | Comparative Analysis of Immune Repertoires between Bactrian Camel's Conventional and Heavy-Chain Antibodies |
| Q90211754 | Current Approaches and Future Perspectives for Nanobodies in Stroke Diagnostic and Therapy |
| Q55256331 | Design of a humanized anti vascular endothelial growth factor nanobody and evaluation of its in vitro function. |
| Q34829527 | Discovery of novel candidate therapeutics and diagnostics based on engineered human antibody domains. |
| Q41347803 | Dual beneficial effect of interloop disulfide bond for single domain antibody fragments |
| Q36140177 | Engineered Autonomous Human Variable Domains |
| Q34650980 | Engineered antibody fragments and the rise of single domains |
| Q57692156 | Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor |
| Q35062276 | Generation of heavy-chain-only antibodies in mice |
| Q39763668 | High affinity anti-inorganic material antibody generation by integrating graft and evolution technologies: potential of antibodies as biointerface molecules |
| Q37033589 | In vivo neutralization of α-cobratoxin with high-affinity llama single-domain antibodies (VHHs) and a VHH-Fc antibody |
| Q35151385 | Isolation and optimization for affinity and biophysical characteristics of anti-CCL17 antibodies from the VH1-69 germline gene |
| Q41382042 | Molecular dynamics simulations and docking enable to explore the biophysical factors controlling the yields of engineered nanobodies |
| Q46793465 | Monovinyl sulfone β-cyclodextrin. A flexible drug carrier system |
| Q60919458 | Multispecific Antibody Development Platform Based on Human Heavy Chain Antibodies |
| Q45161404 | Mutational analysis of domain antibodies reveals aggregation hotspots within and near the complementarity determining regions |
| Q47797367 | Nanobodies: Chemical Functionalization Strategies and Intracellular Applications. |
| Q98466240 | Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics |
| Q37789032 | Nanobodies®: proficient tools in diagnostics |
| Q37829737 | Nanobody; an old concept and new vehicle for immunotargeting |
| Q57260221 | Non-Antibody Scaffolds as Alternative Therapeutic Agents |
| Q46773708 | Overcoming resistance with designer immunotoxins |
| Q36711051 | Production, crystallization and X-ray diffraction analysis of two nanobodies against the Duffy binding-like (DBL) domain DBL6ℇ-FCR3 of the Plasmodium falciparum VAR2CSA protein. |
| Q24676749 | Properties, production, and applications of camelid single-domain antibody fragments |
| Q48007659 | Protein production in Yarrowia lipolytica via fusion to the secreted lipase Lip2p |
| Q38230884 | Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer |
| Q34407012 | Rotavirus A-specific single-domain antibodies produced in baculovirus-infected insect larvae are protective in vivo. |
| Q38628712 | Single-domain antibodies for biomedical applications |
| Q49358130 | Stability-Diversity Tradeoffs Impose Fundamental Constraints on Selection of Synthetic Human VH/VL Single-Domain Antibodies from In Vitro Display Libraries |
| Q61814870 | Toxin Neutralization Using Alternative Binding Proteins |
| Q42371906 | Unveiling a Drift Resistant Cryptotope within Marburgvirus Nucleoprotein Recognized by Llama Single-Domain Antibodies |
Search more.